Literature DB >> 8739789

Varicella pneumonia in a healthy adult presenting with severe respiratory failure.

T Shirai1, K Sano, S Matsuyama, Y Honjo, M Takashima, Y Sasada, S Takayanagi, K Nagamatsu, M Nawano, M Fushimi, S Imokawa, A Sato.   

Abstract

We describe a case of varicella pneumonia in a 24-year-old healthy man presenting with severe respiratory failure. A chest radiograph showed diffuse, bilateral airspace consolidation; additional complications included liver dysfunction and thrombocytopenia. However, treatment with intravenous acyclovir and gamma-globulin improved his clinical symptoms and signs. A greater than four-fold change in paired titers of the varicella-zoster virus antibody was observed. Bronchoalveolar lavage performed during the recovery phase revealed increased total cell and lymphocyte counts and a decreased CD4:CD8 ratio of T lymphocytes. Transbronchial lung biopsy findings were compatible with a diagnosis of interstitial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739789     DOI: 10.2169/internalmedicine.35.315

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Clinical characteristics, management and prognostic factors in patients with probable severe acute respiratory syndrome (SARS) in a SARS center in Taiwan.

Authors:  Chun-Yu Liu; Lin-Ju Huang; Chung-Hsu Lai; Hsin-Pai Chen; Te-Li Chen; Chang-Phone Fung; Cheng-Yi Liu
Journal:  J Chin Med Assoc       Date:  2005-03       Impact factor: 2.743

2.  Varicella pneumonitis in an immunocompetent patient.

Authors:  I Masih; R Boyle; A Donnelly; A Soye; J Kidney
Journal:  BMJ Case Rep       Date:  2011-03-03

Review 3.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.